We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Coronavirus Test Works 10 Times Faster

By LabMedica International staff writers
Posted on 14 Apr 2020
A new testing method for COVID-19 can confirm the presence of the virus 4-10 times faster than the current method of extracting ribonucleic acid (RNA) molecules from a patient’s swab sample to see whether they contain viral RNA. More...
In addition to being equally accurate, the new test does not use specially produced test kits or reagents needed for extracting RNA and instead uses materials commonly found in diagnostic labs, thus making it significantly cheaper and reducing dependence on imported testing materials.

The new testing method for COVID-19 has been developed by researchers from the Hebrew University of Jerusalem (Jerusalem, Israel). The COVID-19 testing kits currently in use extract RNA molecules from a patient's sample to determine if they have viral RNA within them to confirm the presence of the coronavirus. However, these test kits require testing materials, such as complex reagents to extract the RNA for analysis, which are in short supply globally, thus slowing down the rate of testing and increasing the rate of infection.

The Hebrew University researchers have devised a new COVID-19 testing method using a homemade solution that is more easily available and cheaper than the kits. Instead of complex reagents, their test uses tiny magnetic beads to extract RNA for analysis and can be performed both robotically as well as manually. The beads are also recyclable and can be reused to perform future tests. The method was tested on hundreds of samples and all the tests came out identical to the results obtained using the current test kits. The bead method extracted RNA is also ready for analysis four to 10 times more quickly than most other methods.

The researchers believe if their COVID-19 testing method can help labs significantly eliminate the testing bottleneck by reducing their dependence on external factors. The researchers are now developing a method based on genomic sequencing tools that will allow tens of thousands of samples to be tested simultaneously instead of the current rate of thousands of tests.

Related Links:
The Hebrew University of Jerusalem

Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.